Attitude of BRCA1/2 mutation carriers towards fertility preservation, family planning and preimplantation genetic testing (PGT) for the next-generation primary prevention of breast and ovarian cancer

被引：0
|
作者：
Nahshon, C. [1 ]
Oron, G. [1 ]
Kugelman, N. [1 ]
Younes, G. [1 ]
Lavie, O. [2 ]
机构：
[1] Lady Davis Carmel Med Ctr, Obstet & Gynecol Dept, IVF Unit, Haifa, Israel
[2] Lady Davis Carmel Med Ctr, Dept Obstet & Gynecol, Haifa, Israel
来源：
HUMAN REPRODUCTION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-738
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Leendert H Zaaijer
    Helena C van Doorn
    Marian J E Mourits
    Marc van Beurden
    Joanne A de Hullu
    Muriel A Adank
    Luc R C W van Lonkhuijzen
    Hans F A Vasen
    Brigitte F M Slangen
    Katja N Gaarenstroom
    Ronald P Zweemer
    Peggy M L H Vencken
    Caroline Seynaeve
    Mieke Kriege
    British Journal of Cancer, 2016, 115 : 1174 - 1178
  • [22] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Zaaijer, Leendert H.
    van Doorn, Helena C.
    Mourits, Marian J. E.
    van Beurden, Marc
    de Hullu, Joanne A.
    Adank, Muriel A.
    van Lonkhuijzen, Luc R. C. W.
    Vasen, Hans F. A.
    Slangen, Brigitte F. M.
    Gaarenstroom, Katja N.
    Zweemer, Ronald P.
    Vencken, Peggy M. L. H.
    Seynaeve, Caroline
    Kriege, Mieke
    BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1174 - 1178
  • [23] Risk of primary and contralateral breast cancer in BRCA1/2 mutation carriers previously affected with ovarian cancer
    Heemskerk-Gerritsen, B. A. M.
    Hooning, M. J.
    van Doorn, H. C.
    Collee, M.
    Koppert, L. B.
    Jager, A.
    van den Ouweland, A. M. W.
    Seynaeve, C.
    Kriege, M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 528 - 528
  • [24] Risk of primary and contralateral breast cancer in BRCA1/2 mutation carriers previously affected with ovarian cancer
    Heemskerk-Gerritsen, B. A. M.
    Hooning, M. J.
    van Doorn, H. C.
    Collee, M. J.
    Koppert, L. B.
    Jager, A.
    van den Ouweland, A. M. W.
    Netherlands, H.
    Seynaeve, C.
    Kriege, M.
    CANCER RESEARCH, 2017, 77
  • [25] Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?
    Phillips, Kelly-Anne
    Lindeman, Geoffrey J.
    FUTURE ONCOLOGY, 2014, 10 (04) : 499 - 502
  • [26] Genetic anticipation among BRCA1/2 mutation carriers with breast cancer
    Kedmi, Aviya
    Kaduri, Luna
    Grinshpun, Albert
    Shkedi, Shiri
    Meiner, Vardiella
    Hamburger, Tamar
    Maimon, Ofra
    Peretz, Tamar
    CANCER RESEARCH, 2020, 80 (04)
  • [27] Next-generation sequencing in BRCA1/2-negative breast and ovarian cancer families.
    Hauke, Jan
    Heimbach, Andre
    Richters, Lisa Katharina
    Kroeber, Sandra
    Altmuller, Janine
    Thiele, Holger
    Nuernberg, Peter
    Wappenschmidt, Barbara
    Neidhardt, Guido
    Rhiem, Kerstin
    Schmutzler, Rita K.
    Hahnen, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers
    James, P. A.
    Harris, M.
    Lindeman, G. J.
    Mitchell, G.
    JOURNAL OF MEDICAL GENETICS, 2008, 45 (11) : 765 - 766
  • [29] Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers
    Hopper, John L.
    Dowty, James G.
    Apicella, Carmel
    Southey, Melissa C.
    Giles, Graham G.
    Winship, Ingrid
    JOURNAL OF MEDICAL GENETICS, 2008, 45 (07) : 409 - 410
  • [30] A computer model to simulate family history of breast/ovarian cancer in BRCA1 mutation carriers
    Bajdik, CD
    Raboud, JM
    Schechter, MT
    McGillivray, BC
    Gallagher, RP
    MATHEMATICAL BIOSCIENCES, 2001, 171 (01) : 99 - 111
12345